Organización Sanitaria Integrada Bilbao-Basurto
Osakidetza Organization
Iván Alejandro
Ferraz Amaro
Publications by the researcher in collaboration with Iván Alejandro Ferraz Amaro (17)
2024
-
Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis
European Journal of Internal Medicine
-
Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature
Arthritis Research and Therapy, Vol. 26, Núm. 1
-
Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients
RMD open, Vol. 10, Núm. 2
-
Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients
Seminars in Arthritis and Rheumatism, Vol. 68
2023
-
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
Seminars in Arthritis and Rheumatism, Vol. 58
-
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836
-
Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patients
Seminars in Arthritis and Rheumatism, Vol. 60
2022
-
Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients
Seminars in Arthritis and Rheumatism, Vol. 57
-
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients
Seminars in Arthritis and Rheumatism, Vol. 55
-
Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
Frontiers in Immunology, Vol. 13
-
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
Therapeutic Advances in Musculoskeletal Disease, Vol. 14
-
Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype
Clinical and experimental rheumatology, Vol. 40, Núm. 4, pp. 727-733
2021
-
Cranial and extracranial giant cell arteritis do not have different HLA-DRB1 and HLA-B association in Caucasian individuals
Arthritis Research and Therapy
-
Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis
Therapeutic Advances in Musculoskeletal Disease, Vol. 13
-
Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients
Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 2, pp. 395-403
-
Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study
Arthritis Research and Therapy, Vol. 23, Núm. 1
2019
-
Identification of a 3′-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study
Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 351-360